Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Noile-Immune Biotech Inc.

www.noile-immune.com/english

Latest From Noile-Immune Biotech Inc.

New Takeda R&D Collabs Aim To Boost IO Pipeline

In moves aimed at boosting its presence in the immuno-oncology field, Takeda unveils a series of new research collaborations it believes will lead to pipeline gains in this critical field over the next few years.

Cancer Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Noile-Immune Biotech Inc.
  • Senior Management
  • Hidenobu Ishizaki, MD, PhD, Pres.
    Koji Tamada, MD, PhD, CMO & CSO
  • Contact Info
  • Noile-Immune Biotech Inc.
    7-17-2 Ginza
    Chuo-ku
    Tokyo, 104-0061
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register